Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-000114

Options or other derivatives

  • CHIEF BUSINESS OFFICER acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Snow David P. CHIEF BUSINESS OFFICER 2019-01-30 Grant or award · Stock Options +55,000 55,000 D
Snow David P. CHIEF BUSINESS OFFICER 2019-01-30 Grant or award · Restricted Stock Units +25,000 25,000 D
Loading xslF345X03/form4-01312019_040109.xml…